Trial Profile
Phase I QTc trial of delafloxacin versus moxifloxacin and placebo.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Sep 2012
Price :
$35
*
At a glance
- Drugs Delafloxacin (Primary) ; Moxifloxacin
- Indications Bacterial infections
- Focus Adverse reactions
- 15 Sep 2012 New trial record
- 11 Sep 2012 Results have been presented at ICAAC-2012 according to a Rib-X Pharmaceuticals media release. Results were also summarised in the media release.